• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Syria - Circulating Vaccine-Derived Poliovirus type 2 Outbreak Situation Report #27 - 19 December 2017

Shiloh

Shiloh

Editor, Senior Moderator
Source: https://reliefweb.int/report/syrian...outbreak-situation-report-27-19-december-2017
[h=1]Syria cVDPV2 Outbreak Situation Report #27 - 19 December 2017[/h] Report

from World Health Organization, UN Children's Fund Published on 19 Dec 2017 ? View Original


application-pdf.png
Download PDF (1.32 MB)


Key highlights
  • No new cases of cVDPV2 were reported this week. The most recent case (by date of onset) is 21 September 2017 from Boukamal district.
  • The total number of confirmed cVDPV2 cases remains 74.
  • Planning continues for the second phase of the outbreak response. GPEI continues to assist the Syrian Ministry of Health in the planning process.
  • The second phase of the outbreak response will utilize mOPV2 and IPV in two additional immunization rounds through house-to-house and fixed center vaccination...
 
You must log in or register to reply here.
Back
Top Bottom